
Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
2.070
Open
2.060
VWAP
2.01
Vol
187.49K
Mkt Cap
71.60M
Low
1.965
Amount
376.65K
EV/EBITDA(TTM)
--
Total Shares
28.81M
EV
50.07M
EV/OCF(TTM)
--
P/S(TTM)
2.01
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
9.15M
+21.62%
--
--
12.86M
+39.61%
--
--
17.60M
+45.85%
--
--
Estimates Revision
The market is revising Downward the revenue expectations for Myomo, Inc. (MYO) for FY2025, with the revenue forecasts being adjusted by -2.54% over the past three months. During the same period, the stock price has changed by -53.50%.
Revenue Estimates for FY2025
Revise Downward

-2.54%
In Past 3 Month
Stock Price
Go Down

-53.50%
In Past 3 Month
5 Analyst Rating

337.19% Upside
Wall Street analysts forecast MYO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MYO is 8.70 USD with a low forecast of 6.50 USD and a high forecast of 11.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
0 Hold
0 Sell
Strong Buy

337.19% Upside
Current: 1.990

Low
6.50
Averages
8.70
High
11.50

337.19% Upside
Current: 1.990

Low
6.50
Averages
8.70
High
11.50
Alliance Global Partners
Buy
maintain
2025-06-26
Reason
Alliance Global Partners
Price Target
2025-06-26
maintain
Buy
Reason
Alliance Global Partners lowered the firm's price target on Myomo to $6.50 from $6.75 and keeps a Buy rating on the shares following the analyst day. The firm cites minor reductions in its revenue forecast for the target trim but remains confident in the positive fundamental progress of the company.
Craig-Hallum
Buy
downgrade
$10 -> $8
2025-06-23
Reason
Craig-Hallum
Price Target
$10 -> $8
2025-06-23
downgrade
Buy
Reason
Craig-Hallum
Buy
downgrade
$11 -> $10
2025-05-08
Reason
Craig-Hallum
Price Target
$11 -> $10
2025-05-08
downgrade
Buy
Reason
Craig-Hallum lowered the firm's price target on Myomo to $10 from $11 and keeps a Buy rating on the shares following a mixed Q1 update. Q2 guidance disappointed, with revenue expected between $9.0M-$9.5M versus Street expectations of $10.9M.
Ascendiant Capital
Edward Woo
Strong Buy
Maintains
$9 → $11
2025-03-17
Reason
Ascendiant Capital
Edward Woo
Price Target
$9 → $11
2025-03-17
Maintains
Strong Buy
Reason
HC Wainwright & Co.
Sean Lee
Strong Buy
Maintains
$7.5 → $9.5
2025-03-12
Reason
HC Wainwright & Co.
Sean Lee
Price Target
$7.5 → $9.5
2025-03-12
Maintains
Strong Buy
Reason
Craig-Hallum
Craig Knickerbocker
Strong Buy
Maintains
$9 → $11
2025-03-11
Reason
Craig-Hallum
Craig Knickerbocker
Price Target
$9 → $11
2025-03-11
Maintains
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Myomo Inc (MYO.A) is -12.02, compared to its 5-year average forward P/E of -11.72. For a more detailed relative valuation and DCF analysis to assess Myomo Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
-11.72
Current PE
-12.02
Overvalued PE
1.95
Undervalued PE
-25.39
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
-12.42
Current EV/EBITDA
-13.19
Overvalued EV/EBITDA
9.88
Undervalued EV/EBITDA
-34.73
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
2.63
Current PS
1.42
Overvalued PS
4.23
Undervalued PS
1.04
Financials
Annual
Quarterly
FY2025Q1
YoY :
+161.88%
9.83M
Total Revenue
FY2025Q1
YoY :
-9.48%
-3.52M
Operating Profit
FY2025Q1
YoY :
-9.66%
-3.47M
Net Income after Tax
FY2025Q1
YoY :
-20.00%
-0.08
EPS - Diluted
FY2025Q1
YoY :
+1.28%
-3.35M
Free Cash Flow
FY2025Q1
YoY :
+9.78%
67.23
Gross Profit Margin - %
FY2025Q1
YoY :
-65.51%
-35.24
Net Margin - %
Trading Trends
Insider
Insiders areBuying! The selling amount has increased 954.34% over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
412.6K
USD
2
6-9
Months
0.0
USD
0
0-12
Months
33.3K
USD
2
Bought
0-3
4
390.1K
USD
Months
3-6
1
37.0K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
195.7K
Volume
1
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
1
900.0K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders areBuying! The selling amount has increased 954.34% over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
412.6K
USD
2
6-9
Months
0.0
USD
0
0-12
Months
33.3K
USD
2
Bought
0-3
4
390.1K
USD
Months
3-6
1
37.0K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
MYO News & Events
Events Timeline
2025-05-07 (ET)
2025-05-07
17:12:40
Myomo reports Q1 EPS (8c), consensus (8c)

2025-03-10 (ET)
2025-03-10
16:12:32
Myomo reports Q4 EPS (1c), consensus (2c)

2024-12-04 (ET)
2024-12-04
15:07:32
Myomo announces common stock offering, no amount given

Sign Up For More Events
Sign Up For More Events
News
4.0
06-23BenzingaCraig-Hallum Maintains Buy on Myomo, Lowers Price Target to $8
1.0
06-18NewsfilterMyomo Provides Highlights of Today's Investor & Analyst Day Event
4.0
06-05BenzingaAscendiant Capital Maintains Buy on Myomo, Raises Price Target to $11.5
Sign Up For More News
People Also Watch

TTD
Trade Desk Inc
80.210
USD
-1.51%

FSK
FS KKR Capital Corp
22.370
USD
-0.49%

LYFT
Lyft Inc
14.760
USD
0.00%

MNDY
monday.com Ltd
291.800
USD
+0.68%

PTON
Peloton Interactive Inc
6.290
USD
+0.16%

ENVX
Enovix Corp
15.540
USD
-2.45%

LCID
Lucid Group Inc
3.040
USD
-2.56%

IDXX
IDEXX Laboratories Inc
514.610
USD
-0.79%

COF
Capital One Financial Corp
218.280
USD
+0.13%

QS
Quantumscape Corp
14.640
USD
+7.65%
FAQ

What is Myomo Inc (MYO) stock price today?
The current price of MYO is 1.99 USD — it has decreased -2.93 % in the last trading day.

What is Myomo Inc (MYO)'s business?

What is the price predicton of MYO Stock?

What is Myomo Inc (MYO)'s revenue for the last quarter?

What is Myomo Inc (MYO)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Myomo Inc (MYO)'s fundamentals?

How many employees does Myomo Inc (MYO). have?
